Vinorelbine
Product manufactured by Actavis Pharma, Inc.
Indications and Purposes
1 Indications And Usage Vinorelbine Injection Is Indicated: In Combination With Cisplatin For First-Line Treatment Of Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc) As A Single Agent For The Treatment Of Patients With Metastatic Nsclc Vinorelbine Injection Is A Vinca Alkaloid Indicated: In Combination With Cisplatin For First-Line Treatment Of Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc) ( 1 ) As A Single Agent For First-Line Treatment Of Patients With Metastatic Nsclc ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Vinorelbine Tartrate |